Sherrid, Mark V.

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet

Cardiomyopathy and Myosin StudiesBlood Pressure and Hypertension Studies

Cited by 1,296

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology

Cardiomyopathy and Myosin StudiesViral Infections and Immunology Research

Cited by 410

Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With β-Blockade or Verapamil

Sherrid, M. V., Shetty, A., Winson, G., Kim, B., Musat, D., Alviar, C. L., Homel, P., Balaram, S. K., & Swistel, D. G. (2013) · Circulation Heart Failure

Cardiomyopathy and Myosin StudiesViral Infections and Immunology Research

Cited by 178

Successful medical therapy of mitral anular abscess complicating infective endocarditis

Kunis, R. L., Sherrid, M. V., McCabe, J. B., Grieco, M. H., & Dwyer, E. M. (1986) · Journal of the American College of Cardiology

Infective Endocarditis Diagnosis and ManagementInfectious Diseases and Tuberculosis

Cited by 29

Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting

Sirak, T. E., & Sherrid, M. V. (2008) · Chest

Cardiomyopathy and Myosin StudiesTakotsubo Cardiomyopathy and Associated Phenomena

Cited by 13